For me, this thing is no longer “on” , as in on my account. Sold all the rest, half a week before MRNA ‘s great news about melanoma treatment, the other half a week after that news. Each time 100% of proceeds went into MRNA.

My thinking was the same as others here, pipeline waiting way too long on a label extension for negative symptoms, and Rhett…with fingers crossed for over two years waiting for a buyout. From there, my thinking was to find the best breakthrough, medical disruptor possible. Hence MRNA. My remaining biotech is GRTS…who also dabbles in development on mRNA potential treatments.

So, since I’m marginally invested in biotech, down from 85+% two years and longer, I guess you can predict we have seen the bottom in biotech..one remembers failures a lot more clearly than successes, so my history, or at least recollection of my history, is to sell at the wrong time.

Happy hunting to all, have a great holiday season and a safe, healthy, cyber attack free new year and beyond.

Michael, Signing off the ACAD board , a dedicated- and too often frustrated, disappointed member since ( I don’t know for sure) 2007!